We are live on ! Find out more
SQZ

SQZ Biotechnologies Company
SQZ

Delisted

SQZ was delisted on the 3rd of July, 2023.

Back to rankings

48 hedge funds and large institutions have $33.5M invested in SQZ Biotechnologies Company in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

9% less funds holding

Funds holding: 53 → 48 (-5)

15% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 13

29% less capital invested

Capital invested by funds: $47.1M → $33.5M (-$13.7M)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
48
Holders Change
-5
Holders Change %
-9.43%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
11
Reduced
13
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$262K
2
RC
RBF Capital
California
+$150K
3
Stifel Financial
Stifel Financial
Missouri
+$75.5K
4
BCM
Bridgeway Capital Management
Texas
+$75K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$42.3K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$385K
2
Millennium Management
Millennium Management
New York
-$293K
3
Citadel Advisors
Citadel Advisors
Florida
-$139K
4
Morgan Stanley
Morgan Stanley
New York
-$71.8K
5
Goldman Sachs
Goldman Sachs
New York
-$66.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
26
SG Americas Securities
New York
$36K +$600 +200 +1%
Two Sigma Investments
27
Two Sigma Investments
New York
$31K -$336 -112 -0.8%
Morgan Stanley
28
Morgan Stanley
New York
$30K -$71.8K -23,936 -64%
Balyasny Asset Management
29
Balyasny Asset Management
Illinois
$28K +$37.2K +12,404 New
HSBC Holdings
30
HSBC Holdings
United Kingdom
$27K -$165 -55 -0.5%
BSB
31
Bangor Savings Bank
Maine
$26K – – –
Prudential Financial
32
Prudential Financial
New Jersey
$26K – – –
TRCT
33
Tower Research Capital (TRC)
New York
$24K +$31.7K +10,561 New
EMG
34
ETF Managers Group
New Jersey
$20K -$786 -262 -3%
BTI
35
Blue Trust Inc
Georgia
$13K – – –
BAM
36
Baldrige Asset Management
Pennsylvania
$11K – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$9.68K +$12.7K +4,247 New
UBS Group
38
UBS Group
Switzerland
$8K +$1.03K +344 +11%
JP Morgan Chase
39
JP Morgan Chase
New York
$5K -$385K -128,172 -98%
Barclays
40
Barclays
United Kingdom
$4K – – –
TWC
41
TD Waterhouse Canada
Ontario, Canada
$3.15K +$3K +1,000 New
National Bank of Canada
42
National Bank of Canada
Quebec, Canada
$2K – – –
FDCDDQ
43
Federation des caisses Desjardins du Quebec
Quebec, Canada
$239 – – –
Millennium Management
44
Millennium Management
New York
– -$293K -92,286 Closed
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
– -$43K -13,549 Closed
PP
46
PDT Partners
New York
– -$37K -11,740 Closed
OQS
47
Occudo Quantitative Strategies
Florida
– -$36K -11,307 Closed
Russell Investments Group
48
Russell Investments Group
United Kingdom
– -$26K -8,192 Closed
Group One Trading
49
Group One Trading
Illinois
– -$2.7K -900 -90%
Citigroup
50
Citigroup
New York
– -$1.64K -548 -97%
1
2
3

SQZ Hedge Fund Activity: Q3 2022 in Review

48 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in SQZ Biotechnologies Company (SQZ) for Q3 2022, worth a combined $33.5M — down 29% from $47.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of SQZ and 4 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 11 added.

The largest buyer was 683 Capital Management, adding an estimated $262K. The largest seller was JP Morgan Chase, cutting an estimated $385K.

  • 48 institutional investors held SQZ Biotechnologies Company (SQZ) as of Q3 2022, down from 53 in Q2 2022.
  • Funds reported $33.5M of SQZ Biotechnologies Company stock for Q3 2022, down 29% quarter-over-quarter.
  • 4 funds opened new SQZ Biotechnologies Company positions in Q3 2022 and 9 closed out, a net change of -5 holders.
  • The largest SQZ Biotechnologies Company buyer in Q3 2022 was 683 Capital Management, an estimated $262K added.
  • The largest SQZ Biotechnologies Company seller in Q3 2022 was JP Morgan Chase, an estimated $385K sold.

Based on aggregated 13F filings for Q3 2022.